- 不限
- 2025年09月04日 [星期四]
- 2025年09月05日 [星期五]
- 2025年09月06日 [星期六]
- 2025年09月07日 [星期日]
- 不限
- 三层-主会场-地球村
- 三层-F302
- 三层-F303
- 三层-F304A
- 三层-F304B
- 三层-F305
- 三层-F306
- 三层-F307A
- 三层-F307B
- 三层-F308A
- 三层-F308B
- 六层-F627
- 手术演示-结石
- 手术演示-前列腺
- 手术演示-机器人及腹腔镜
- 不限
- 主会场
- 会前会-大师班
- 微创-F302
- 肿瘤 F306
- 尿控-F303
- 结石-F308B
- 机器人-F304A
- 工程-F304A
- 国际-F304B
- 感染与炎症-F305
- 肾移植-F305
- 激光-F307A
- 基层-F307A
- 女性-F307B
- 男科-F307B
- 护理-F308A
- 小儿-F627
- 转化与基础-F627
- 闭幕式-地球村
- 结石专场-手术演示
- 前列腺专场-手术演示
- 机器人及腹腔镜-手术演示
2025年09月06日 [星期六]
三层-F304B
| 1 | 08:00-08:10 |
Welcome Speech |
|
||||||
| 1 | 08:10-08:25 |
Trageting Glycolysis in NEPC |
|
||||||||||
| 2 | 08:25-08:40 |
IL-17 in prostate cancer |
|
||||||||||
| 3 | 08:40-08:55 |
Role of genetic testing in prostate cancer |
|
||||||||||
| 4 | 08:55-09:10 |
Discussion |
|
||||||||||
| 1 | 09:10-09:25 |
The impact of SABV on cancer |
|
||||||||||
| 2 | 09:25-09:40 |
Age-associated remodeling of the prostate cancer microenvironment by spatial transcriptomics and single-cell genomic profiling |
|
||||||||||
| 3 | 09:40-09:55 |
Predictive models and Al in the management of male LUTS |
|
||||||||||
| 4 | 09:55-10:10 |
Discussion |
|
||||||||||
| 1 | 10:10-10:25 |
En bloc resection of bladder tumour (ERBT): Revolutionizing bladder cancer surgery |
|
||||||||||
| 2 | 10:25-10:40 |
Hot topics in the surgical management of non muscleinvasive bladder cancer |
|
||||||||||
| 3 | 10:40-10:55 |
A noninvasive and living biomarker for human bladder cancer |
|
||||||||||
| 4 | 10:55-11:10 |
Copper-dependent nutrient volubilities for improving prostate cancer therapy |
|
||||||||||
| 5 | 11:10-11:25 |
Discussion |
|
||||||||||
| 1 | 13:35-13:50 |
Redox imbalance: an achille heel of NEPC |
|
||||||||||
| 2 | 13:50-14:05 |
Targeting the powerhouse: mitochondrial uncouplers for the treatment of lethal prostate cancer |
|
||||||||||
| 3 | 14:05-14:20 |
MAPK4 as an emerging oncogenic driver for prostate cancer |
|
||||||||||
| 4 | 14:20-14:35 |
Epitranscriptiomic driver in prostate cancer |
|
||||||||||
| 5 | 14:35-14:50 |
Discussion |
|
||||||||||
| 1 | 14:50-15:05 |
CRISPR screen identifies novel tergets for prostate cancer treatment |
|
||||||||||
| 2 | 15:05-15:20 |
Targeting N-Myc proteostasis in advanced prostate cancer |
|
||||||||||
| 3 | 15:20-15:35 |
Understanding the recurrence mechanisms of NMIBC from a clinical perspective |
|
||||||||||
| 4 | 15:35-15:50 |
The Cardio-oncology in prostate cancer patients |
|
||||||||||
| 5 | 15:50-16:05 |
Discussion |
|
||||||||||
| 1 | 16:05-16:20 |
AI-assisted prostate cancer biopsy |
|
||||||||||
| 2 | 16:20-16:35 |
Dual roles of BRD4 in advanced prostate cancer: transcriptional regulator and kinase |
|
||||||||||
| 3 | 16:35-16:50 |
Transforming urologic cancer care: The power of artificial intelligence and molecular insights |
|
||||||||||
| 4 | 16:50-17:10 |
Discussion |
|
||||||||||